Skip to main content

Table 3 Predefined humane endpoints leading to euthanasia of pigs in experimental S. suis infections published between 2000—2021

From: A critical review on experimental Streptococcus suis infection in pigs with a focus on clinical monitoring and refinement strategies

Study type

Experimental infection

Humane endpoints

Reference

Age of pigs in weeks

Serotype

Route

path.

4–5

2

i.n.

score > 2 on attitude or locomotion

[43, 102]a

vac.

8

2

aerosol

[101]a

vac.

8

2

i.v.

severe clinical signs (score > 4)

[7]a

vac.

11–12

2

i.p.

animals unresponsive for stimuli; CNS dysfunction; lameness score of 3

[26]a

path.

5

2

i.n.

“high clinical scoring”

[52]a

vac.

7–8

2

aerosol

[119]a

vac.

7

2

i.p.

score = 3 in either category and a body temperature above 40°C for 2 consecutive days

[75]a,b,c

path.

5

7

i.v.

fever ≥ 40.5°C, apathy and anorexia (persisting over 24h [24]  /32h [51]); acute polyarthritis; CNS dysfunction; score ≥ 25 [51, 24] 

[23]a,b,c

vac.

8

14

i.n.

[24]a,b,c

8–9

9

i.v.

[51] a,b,c

path.

4–5

2

i.n.

high fever (≥ 40.5°C), apathy and anorexia persisting over 36h/24h [81] ; CNS dysfunction; acute polyarthritis

[87]b,c

8

2

i.n.

[25]b,c

9

2

i.n.

[30]b,c

vac.

7–8

2

i.n.

[113]b,c

9

9

i.v.

[81]b,c

path.

0–1

2

i.n.

consumption < 75% or more of dispensed diet for four feedings in a row and lameness, fever (> 40°C), or CNS disease

[35]b,c,d

vac.

8–9

2, 7

i.v.

 ≥ 40.5°C, apathy and anorexia; polyarthritis; CNS disorder

[48]b

6, 8

2

i.v.

[44]b

9

2

i.n., i.v.

[82]b

7–8

9

i.v.

[54]b

path.

7–8

2, 9

i.n., i.v.

high fever (≥ 41°C weaners; ≥ 40.5°C growers), apathy and anorexia

[70]b

4–5/7–8

2

i.n.

[84]b

model

7

2

i.v.

fever (≥ 41°C) or CNS dysfunction

[117]b

model

9

2

oral

(severe) clinical signs/disease e.g. arthritis/lameness/swollen joints w/o recumbency; meningitis/central nervous signs

[53]

5–6

2

i.n.

[34]*

1–2

2

i.v., i.n.

[47]

7

2

i.v.

[120]

path.

6

2

s.c.

[78]

6

2

i.n.

[56]

(0)-1

2

i.n.

[38, 39]e

3

/

i.v.

[121]

6-(7)

2

aerosolic

[55, 79, 88]

3

2

i.v.

[62]

3–4

2

i.n.

[37]d

3

2

i.v.

[46]

vac.

9

2

i.n.

[122]

4

2

s.c.

[60]

2–3

2

i.n.

[36]d

8

2

i.v.

[67, 68]

path.

4–5

2

i.v.

not clearly defined (“for animal welfare or ethical reasons”)

[6]

8

2

i.v.

[65]

1

2

i.v., i.n.

[118]

vac.

7

9

i.n.

[72]

9

2

i.v.

[123]

  1. path. study on pathogenesis, vac. study on vaccination, model study on establishment of an infection model
  2. ascoring system included in humane endpoints (h.e.)
  3. bfever included in h.e
  4. cduration of burden included in h.e
  5. dPRRSV and S. suis coinfection
  6. eBordetella bronchiseptica pre infection